DUSP1 and acquired polycythemia vera: These findings suggest that the JAK2V617F+ PV progenitors use DUSP1 activity as a defense against DNA injury, stimulating their growth in the inflammatory milieu and thus recognizing DUSP1 as a possible therapeutic target in PV [92].